Company Description
FOCALTHERICS (NASDAQ: FOCL) is classified in the medical distribution industry within the Electromedical & Electrotherapeutic Apparatus sector and carries a market capitalization of $237.6M, ranking #4,520 among all listed U.S. companies by market cap.
For FY2025, FOCALTHERICS reported revenue of $70.5M with net income of -$29.2M and diluted earnings per share of $-0.78. The company operates at a net profit margin of -41.5%.
This page collects what Stock Titan holds for FOCL, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
FOCALTHERICS (FOCL) stock last closed at $6.09. At a market capitalization of $237.6M, FOCL is classified as a micro-cap stock with approximately 37.5M shares outstanding.
FOCL Rankings
Latest News
FOCALTHERICS has 3 recent news articles, with the latest published 7 days ago. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include earnings date. View all FOCL news →
SEC Filings
FOCALTHERICS has filed 1 recent SEC filing, including 1 Form 8-K. The most recent filing was submitted on June 26, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all FOCL SEC filings →
Financial Highlights
FOCALTHERICS generated $70.5M in revenue in FY2025, retaining a 42.5% gross margin, operating income reached -$24.7M (-35.0% operating margin), and net income was -$29.2M, reflecting a -41.5% net profit margin. Diluted earnings per share stood at $-0.78. The company generated -$16.4M in operating cash flow. With a current ratio of 1.54, the balance sheet reflects a strong liquidity position.
Upcoming Events
Quarterly results release
Earnings conference call
FOCALTHERICS has 2 upcoming scheduled events. The next event, "Quarterly results release", is scheduled for August 13, 2026 (in 6 days). Investors can track these dates to stay informed about potential catalysts that may affect the FOCL stock price.
Short Interest History
Short interest in FOCALTHERICS (FOCL) currently stands at 234.4 thousand shares, up 23.8% from the previous reporting period, representing 0.7% of the float. Since June 2026, short interest has increased by 73.7%. This relatively low short interest suggests limited bearish sentiment. The 5.1 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for FOCALTHERICS (FOCL) currently stands at 5.1 days, up 25.6% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 51% over the past year, indicating either rising short interest or declining trading volume.
FOCL Company Profile & Sector Positioning
FOCALTHERICS (FOCL) operates in the Medical Distribution industry within the broader Electromedical & Electrotherapeutic Apparatus sector and is listed on the NASDAQ. In monthly performance, the stock ranks #374 among all tracked companies.